TRLPF Stock UPDATES Trimel Pharmaceutica (TRLPF) 0.4240 08/30/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Trimel Pharmaceutica (TRLPF) 0.4240 $TRLPF

First Generation Capital Inc. Converts a Portion of Previously Issued Convertible Note of Trimel Pharmaceuticals Corporation
Marketwire - Fri Aug 22, 5:28PM CDT
Mr. Ian Ihnatowycz announced that effective today, he has converted US$5,151,768.08 aggregate amount (of which US$55,002.59 was accrued interest) of obligations owing under the convertible note (the "Note" of Trimel Pharmaceuticals Corporation (the "Issuer" that was issued to First Generation Capital Inc. on July 16, 2014 (and amended on July 28, 2014) into 8,945,796 common shares of the Issuer. In accordance with the terms and conditions of the Note, the conversion price was the U.S. dollar equivalent of Cdn.$0.62 per common share, calculated using the Bank of Canada noon rate of exchange on July 15, 2014 (being a conversion price equal to US$0.5759 per common share).

Trimel Announces New TriVair(TM) Website
Marketwire - Thu Jul 31, 4:06PM CDT
Trimel Pharmaceuticals Corporation (TSX: TRL) announced today that the Company has launched a new website for its dry powder inhalation drug delivery platform TriVair(TM). Winner of the 2009 European Drug Delivery Product Differentiation Innovation of the Year Award, TriVair(TM) is Trimel's novel unit-dose dry powder inhaler / nasal dispersion device. Trimel is interested in establishing partnership arrangements with developers who are looking for a patented, novel dry powder nasal and pulmonary delivery system. For more information, please visit www.trivairdevice.com.

Trimel Provides Corporate Update and Second Quarter 2014 Financial Results
Marketwire - Wed Jul 30, 5:04PM CDT
Trimel Pharmaceuticals Corporation (TSX: TRL) today provided an overview of its corporate accomplishments and reported financial results for the three month period ended June 30, 2014.

First Generation Capital Inc. Amends Previously Issued Convertible Note of Trimel Pharmaceuticals Corporation
Marketwire - Wed Jul 30, 1:56PM CDT
Mr. Ian Ihnatowycz, announced that effective today, he has entered into an amending agreement (the "Amending Agreement" to the US$25 million convertible note (the "Note" of Trimel Pharmaceuticals Corporation (the "Issuer" issued on July 16, 2014 to his private investment holding company First Generation Capital Inc. (the "Offeror" .

Trimel to Provide Corporate Update and Report Second Quarter 2014 Results
Marketwire - Fri Jul 18, 7:01AM CDT
Trimel Pharmaceuticals Corporation (TSX: TRL) will report its second quarter financial results for the period ended June 30, 2014 on July 30, 2014 after market close.

First Generation Capital Inc. Acquires Convertible Note of Trimel Pharmaceuticals Corporation
Marketwire - Thu Jul 17, 1:20PM CDT
Mr. Ian Ihnatowycz announced today that he has acquired a US$25 million convertible note (the "Note" of Trimel Pharmaceuticals Corporation (the "Issuer" through his private investment holding company First Generation Capital Inc. (the "Offeror" . The Note, which pays interest at 9.5% plus the greater of: (a) LIBOR; and (b) 1.0%, and has an initial maturity date of July 16, 2015, is convertible into common shares of the Issuer, in whole or in part at any time after August 21, 2014, at a conversion price, subject to standard anti-dilution adjustments, of the US dollar equivalent of $0.62 (calculated using the July 15, 2014 Bank of Canada noon buying rate for US dollars of US$1 equals $1.0766). The purchase was made on a private placement basis from the Issuer.

IIROC Trade Resumption - Trimel Pharmaceuticals Corporation
Newsfile Corp - Thu Jul 17, 12:51PM CDT
Trading resumes in:

IIROC Trade Halt - Trimel Pharmaceuticals Corporation
Newsfile Corp - Thu Jul 17, 12:50PM CDT
The following issues have been halted by IIROC:

Should Trimel Pharmaceuticals (TRLPF) Be On Your Radar Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 7:49AM CDT
Trimel Pharmaceuticals (TRLPF)has been overlooked by investors but it has actually seen estimates rise over the past month.

Trimel to Present at the JMP Securities Healthcare Conference
Marketwire - Wed Jun 18, 2:00PM CDT
Trimel Pharmaceuticals Corporation (TSX: TRL) today announced that management is scheduled to present an overview of the Company at the JMP Securities Healthcare Conference at the Westin New York Grand Central, New York on June 24, 2014 at 12:00 p.m. (Eastern time). The presentation materials will also be made available on the Trimel website at www.trimelpharmaceuticals.com.

Trimel to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference
Marketwire - Wed Jun 18, 1:21AM CDT
Trimel Pharmaceuticals Corporation (TSX: TRL) today announced that management is scheduled to present an overview of the Company at the 2014 Bloom Burton & Co. Healthcare Investor Conference at the Toronto Board of Trade on June 18th, 2014 at 2:30 p.m. (Eastern time). The presentation materials will also be made available on the Trimel website at www.trimelpharmaceuticals.com.

Trimel Reports Additional Results From Tefina(TM) Phase II Clinical Trial
Marketwire - Mon Jun 16, 5:01AM CDT
Trimel Pharmaceuticals Corporation (TSX: TRL) reported results from further analysis of its Phase II clinical trial evaluating the efficacy and safety of Tefina(TM), a "use-as-required" testosterone nasal gel for the treatment of Female Orgasmic Disorder (FOD).




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Thanksgiving AI Talk Needs Better Safety Questions

Updated Category News Views 108

Thanksgiving has somehow acquired a new household hazard: somebody casually pasting private information into a chatbot between football and dessert. SBS CyberSecurity’s point is sensible, and it lands because this is no longer a niche tech habit. Pew Research Center says 49% of U.S. adults use AI chatbots, up from roughly one-third in 2024. That kind of adoption curve...

Continue Reading
Ajman Forum Puts Trust at the Center of Crisis Media

Updated Category News Views 39

Rumours do not wait politely for a communications team to finish its meeting. That plain reality sat underneath Abdulla bin Mohammed bin Butti Al Hamed's keynote at Ajman Media Forum 2026, and it is a tougher point than the usual talk about reach, engagement, or flashy new technology. In a crisis, an information vacuum gets filled fast, usually by somebody with no...

Continue Reading
ACOLT Bets on Gold, Craft, and a Sci-Fi Story World

Updated Category News Views 43

A gold pendant moonlighting as a plot device is not the usual luxury pitch, and thank goodness for that. ACOLT, the Denver-based men's fine jewelry house founded by Colton Hindle, plans an international December 2026 launch of its Gold Collection alongside CHRYSON Volume 1: The Arrival, an original science-fiction comic. The actual hand-forged pieces are meant to show up...

Continue Reading
Schloss Johannisberg Leads 2026 Global Vineyard List

Updated Category News Views 179

A 1,200-year-old riesling estate just beat the world at being memorable. Schloss Johannisberg in Germany’s Rheingau has taken No. 1 in The 50 Best Vineyards 2026, moving up from No. 2 last year and also claiming Best Vineyard in Europe. For anyone watching the wine business from the outside, this is not really a story about one bottle edging out another. It is a...

Continue Reading
Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 113

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Ajman Media Forum Puts Trust Ahead of AI Speed in 2026

Updated Category News Views 156

Algorithms may manufacture a flood of words, but they cannot inherit accountability. That was the sensible nerve running through Ajman Media Forum 2026, “The Signal,” inaugurated on November 19 by His Highness Sheikh Ammar bin Humaid Al Nuaimi, Crown Prince of Ajman and Chairman of the Executive Council. For all the fanfare that usually surrounds artificial...

Continue Reading
Rafay's Third Fast 500 Nod Tracks AI Cloud Buildout

Updated Category News Views 24

GPU warehouses are easy to admire and brutally hard to operate like a real business. Rafay Systems landing on Deloitte's 2026 Technology Fast 500 for a third straight year is another signal that the AI infrastructure scramble has moved well beyond simply finding chips. Somebody has to turn all that expensive compute into services customers can provision, use, measure and...

Continue Reading
Innogen's Arcera Deal Tests Its GLP-1 Global Reach

Updated Category News Views 115

A License Deal With Actual Cash Attached Drug licensing announcements can smell like expensive perfume: plenty of promise, hard to tell what is really in the bottle. This one at least arrives with a concrete number. Innogen Pharmaceuticals will receive US$38 million in upfront and near-term milestone payments from Arcera Life Sciences for Efsubaglutide Alfa, including a...

Continue Reading
FLX Opens a New Door to Pre-IPO Deal Flow for Advisors

Updated Category News Views 82

Private-market chatter has been leaking past the velvet rope for years, and advisors are sick of learning about it after a client already has a pitch deck in hand. FLX Networks is responding to that irritation by letting its eligible advisor and wealth-management members review select pre-IPO opportunities shared by other members. Announced November 19, 2026, the move is...

Continue Reading
Getac's Linux Certification Matters at the Rugged Edge

Updated Category News Views 73

Field computers rarely get applause, but they can decide whether a critical operation runs cleanly or turns into a very expensive mess. Getac’s November 19 announcement that its UX10, G140, and V120 rugged devices are certified for Red Hat Enterprise Linux is not the sort of headline that sends investors pounding the table. It is, however, the kind of plumbing work that...

Continue Reading

Top 5 Most Recently Viewed Articles

Globeleq Strengthens Leadership with Alasdair Martin's Appointment

Updated Category News Views 169

Globeleq Welcomes Alasdair Martin as Director of Private Customer Solutions Globeleq, a prominent independent power company in Africa, has appointed Alasdair Martin to the crucial role of Director of Private Customer Solutions. This appointment is a strategic move that aligns with the company's vision for growth through innovation and sustainable energy transformation in...

Continue Reading
Orthofix Medical's Q4 2026 Earnings: Unpacking The Numbers

Updated Category News Views 186

Earnings Breakdown Let's get into the nitty-gritty of Orthofix Medical's earnings for Q4 of 2026. Rollercoaster ride, anyone? They posted an earnings-per-share (EPS) of $0.24, which is a solid beat over the $0.12 consensus estimate. That's a clean 100% overcall—on paper, that's the kind of news that gets you smiling on your way to the bank. Honestly, an earnings double...

Continue Reading
bioAffinity Technologies Achieves Milestone with CyPath® Lung Test

Updated Category News Views 106

bioAffinity Technologies Celebrates Initial Success of CyPath® Lung b>bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), dedicated to advancing noninvasive cancer detection and lung disease diagnostics, has unveiled remarkable outcomes from its recent pilot marketing program for the CyPath® Lung test. Focused on enhancing patient care, the Texas beta launch has seen...

Continue Reading
Hamilton Beach Brands Reports Strong Q3 Performance for 2024

Updated Category News Views 145

Company Overview Hamilton Beach Brands Holding Company (NYSE: HBB) is an established leader in the design, marketing, and distribution of a variety of small electric household appliances and specialty products. With a portfolio that includes well-known consumer brands such as Hamilton Beach® and Proctor Silex®, the company continues its mission to enhance daily living...

Continue Reading
Melexis Expands Treasury Share Holdings with Recent Buyback

Updated Category News Views 155

Melexis Share Buy-Back Program Update Melexis is excited to share an update regarding its ongoing share buy-back program, originally announced several months ago. This initiative aims to enhance shareholder value and stabilize stock prices in today’s dynamic market environment. As part of this program, Melexis has recently engaged in notable share purchases on Euronext...

Continue Reading